PepSeq Provides Massive Platform for Antibody Analyses Posted Monday December 5, 2022 Technology developed at TGen described in new study
MindCrowd 2.0 Launches with New Brain Games, Smartphone Access Posted Wednesday July 20, 2022 One-of-a-kind online study looks for ways to reduce cognitive decline as we age
COVID-19 vaccination activates antibodies targeting parts of virus spike protein shared between coronaviruses Posted Tuesday July 5, 2022 Technology developed by TGen researchers could help fine-tune future vaccines
Circulating Tumor DNA Guides Chemotherapy Use in Stage II Colon Cancer Posted Saturday June 4, 2022 Researchers from TGen, a part of City of Hope, contribute to study supporting value of ctDNA in assessing treatment options
TGen study offers path for late-stage cancer patients wanting to leverage their own health data to guide their care Posted Wednesday May 18, 2022